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lowest-cost 2008 plan. When cost savings were calculated by
individual participant, this equated to a median annual OOP cost
savings of $98.00 (22.3%) per participant. CONCLUSION:
Trained student pharmacists can provide community-based inter-
ventions that reduce OOP prescription drug plan costs among
underserved Medicare populations.
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OBJECTIVE: Falls in the elderly pose signiﬁcant health risk with
substantial effects on health resource utilization and cost; 95% of
hip fractures are due to falls. Previous estimates of the costs of
falls used administrative data which underestimate falls inci-
dence. We aimed to estimate the direct health costs of injurious
falls requiring Emergency Department (ED) care. METHODS:
Information was collected on patients >70 years who presented
to the ED of Vancouver General Hospital. Fallers were identiﬁed
though a search of ED census, ED presenting complaints, ED
consultant records, and patient charts for reports of a fall. From
hospital reports, data were collected on patient demographics,
diagnoses, admission status, and hospital length of stay. Total
costs were estimated for each fall from the third payer perspec-
tive. Unit cost estimates for ED visits, and hospitalizations were
taken from a fully allocated hospital cost model. RESULTS:
Between December 1 2006 and March 31 2007, we identiﬁed
390 falls by 381 individuals costing $2,520,641. The mean age of
fallers was 83.6 years (SD:7.4); 69% were women. Fallers sus-
tained 183 (47%) fractures—these included 70 hip (39%) and
22 pelvic (12%) fractures. Other common diagnoses were
contusions/lacerations (n = 63, 16%), and syncope (n = 31, 8%).
134 (34%) falls resulted in hospital admission with an average
length of stay of 31.6 days (SD:41.59) and mean cost of $18,375
(SD:23601). Logistic regression analysis showed that compared
to those <80 years, those >80 years were more likely to be
hospitalized (OR:1.8, 95% CI:1.1–3.0). Women were more likely
than men to be hospitalized (OR = 1.5, 95% CI:0.9–2.4),
however this association was not statistically signiﬁcant. After
adjusting for age and sex, a diagnosis of “fracture” was the
strongest predictor of hospitalization (OR:15.5, 95% CI:8.2–
27.2). CONCLUSION: Among seniors, the signiﬁcant cost of fall
related hospital admissions warrants increased fall prevention
programs in this population.
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OBJECTIVE: Uterine ﬁbroids are the most common tumours in
women during their reproductive years, yet there is consider-
able paucity of data on treatments’ effectiveness and costs. We
developed a Markov model to compare currently available
treatments with a new Magnetic Resonance Guided Focused
Ultrasound Sound Surgery (MRgFUS). METHODS: Current
practice, comprising of uterine artery embolization (UAE),
myomectomy and hysterectomy, was compared with MRgFUS,
the least invasive procedure. A Markov model was used to
simulate the clinical outcomes, costs, age and quality-of-life
parameters to provide informed decisions on the part of pro-
viders, payers, and patients. The results were expressed as costs
per quality- adjusted-life-year (QALY) gained. The analysis was
conducted from the perspective of the National Health Service
(NHS) in the UK. All model parameters were based on the
most recent literature (post 1999). The effects of uncertainty in
the model’s parameters were explored using extensive determin-
istic and probabilistic sensitivity analysis. RESULTS: MRgFUS
is likely to be cost-effective. In the base scenario, it is dominant,
that is, has a lower cost and better outcomes than existing
treatments, although the QALY difference per woman is small.
MRgFUS remains cost effective (30, 000 per QALY gained)
when using alternative assumptions regarding current practice,
health utility, and the effectiveness of alternative treatments
(complication, recurrence, and procedural death rates). Mul-
tiple simulations show the range of outcomes that might be
expected in all aspects of practice with the result that MRgFUS
remains cost-effective in more than 86% of the simulations.
CONCLUSION: The results of this study support the introduc-
tion of MRgFUS as a treatment for uterine ﬁbroids. A treat-
ment strategy starting with MRgFUS is potentially more
effective and less costly than the current practice.
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OBJECTIVE: A woman’s health-related quality of life (HRQoL)
can be affected by her premenstrual symptoms. The study objec-
tive was to assess the association between HRQoL and score
differences on the Premenstrual Symptoms Impact Survey
(PMSIS), a six-item instrument for measuring impact of premen-
strual symptoms on a woman’s HRQoL. METHODS: Data were
collected on the PMSIS and SF-12 Health Survey from a panel of
representative U.S. women 18–45 years via Internet (N = 971).
PMSIS scores were used to identify women “at risk for PMDD.”
Items from the SF-12 were dichotomized and regressed onto the
standardized PMSIS scores with age as a covariate. Logistic
regression was used to derive odds ratios (OR) for experiencing
a particular outcome as a function of score differences between
“at risk for PMDD” and the population mean of the PMSIS.
RESULTS: The overall sample mean PMSIS score was 26.6 (on a
standardized scale of 0–100 from no impact to severe impact).
Higher PMSIS scores were signiﬁcantly associated with increased
risk of negative HRQL outcomes (p < 0.01). Women identiﬁed as
“at risk for PMDD” (PMSIS score  64) had 383% increased
risk of pain interfering with normal work; 320% increased risk
of doing work or activities less carefully than usual due to emo-
tional problems; 253% increased risk of feeling limited in work
or activities due to physical health or feeling they accomplished
less due to emotional problems; and 196% increased risk of
feeling downhearted and depressed, and feeling little or no
energy. CONCLUSION: There is a signiﬁcant association
between higher PMSIS scores (more severe impact due to pre-
menstrual symptoms) and diminished role functioning, physical
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and mental health well-being. The PMSIS can be a signiﬁcant
predictor of HRQoL in women with PMDD.
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OBJECTIVE: Clinically signiﬁcant PMS and its more severe
form, PMDD, can impact women’s physical health and interfere
with their ability to work. This study used the Physical Compo-
nent Summary (PCS) scores to predict work loss risk associated
with the two diagnoses. METHODS: Two data sources were
used. From the Medical Outcome Study (MOS), PCS scores from
SF-36 Health Survey was regressed onto three work loss
outcomes (inability-to-work-due-to-health-problems at baseline,
work loss follow-ups at 6-months and one-year) with age and
gender as covariates. In an Internet survey, the SF-12 Health
Survey and retrospective component of American College of
Obstetricians and Gynecologists (ACOG) for identifying “at-
risk-for-clinically-signiﬁcant-PMS” and retrospective criteria in
DSM-IV-TR for identifying “at-risk-for-PMDD” were collected
from a panel of representative U.S. women 18–45 years
(N = 971). Given PCS scores from SF-12 in the Survey, regression
coefﬁcients derived from MOS logistic regressions were used to
generate odds ratios (OR) of work loss risk for women with and
without PMS or PMDD. ANOVA tests compared the probability
differences in ORs within each diagnosis. RESULTS: A total
of 17.7% and 6.0% of women were identiﬁed as “at-risk-
for-clinically-signiﬁcant-PMS” and “at-risk-for-PMDD”, respec-
tively. Statistically signiﬁcant differences were observed in all
outcome comparisons in both diagnoses (p < 0.001). Women not
at risk for either diagnosis had risks of work loss comparable to
the general population. Women “at-risk-for-clinically-signiﬁcant-
PMS” had a 139% increased risk of work loss with the concur-
rent state; those who worked at baseline had 32% increased risk
of work loss at both follow-ups. Women “at-risk-for-PMDD”
had a 181% increased risk of work loss at the concurrent state;
those who worked at baseline had 46% increased risk of work
loss at both follow-ups. CONCLUSION: Using PCS scores,
women with either clinically signiﬁcant PMS or PMDD were
more likely to experience work loss than the general population,
especially women with PMDD.
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OBJECTIVE: Clinically signiﬁcant PMS and its more severe
form, PMDD, can affect women mentally and interfere with
their ability to work. This study used the Mental Component
Summary (MCS) scores to predict work loss risk associated with
the two diagnoses. METHODS: Two data sources were used.
From the Medical Outcome Study (MOS), MCS scores from
SF-36 Health Survey was regressed onto three work loss out-
comes (inability-to-work-due-to-health-problems at baseline,
work loss follow-ups at 6-months and one-year) with age and
gender as covariates. In an Internet survey, SF-12 Health Survey
and retrospective component of American College of Obstetri-
cians and Gynecologists (ACOG) for identifying “at-risk-for-
clinically-signiﬁcant-PMS” and retrospective criteria in DSM-
IV-TR for identifying “at-risk-for-PMDD” were collected from a
panel of representative U.S. women 18–45 years (N = 971).
Given MCS scores from SF-12 in the Survey, regression coefﬁ-
cients derived from MOS logistic regressions were used to gen-
erate odds ratios (OR) of work loss risk for women with and
without PMS or PMDD. ANOVA tests compared the probability
differences in ORs within each diagnosis. RESULTS: A total
of 17.7% and 6.0% of women were identiﬁed as “at-risk-
for-clinically-signiﬁcant-PMS” and “at-risk-for-PMDD”, respec-
tively. Statistically signiﬁcant differences were observed in all
outcome comparisons in both diagnoses (p < 0.001). Women not
at risk for either diagnosis had risks of work loss comparable to
the general population. Women “at-risk-for-clinically-signiﬁcant-
PMS” had a 74% increased risk of work loss at the concurrent
state; those who worked at baseline had 53% and 48% increased
risk of work loss at 6-month and 1-year follow-ups. Women
“at-risk-for-PMDD” had a 99% increased risk of work loss at
the concurrent state; those working at baseline had a 70% and
63% increased risk at respective follow-ups. CONCLUSION:
Using MCS scores, women with either clinically signiﬁcant PMS
or PMDD were more likely to experience work loss than the
general population, especially women with PMDD.
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OBJECTIVE: Little is known about women’s preferences and
willingness to pay (WTP) for drug information services in preg-
nancy. Teratology information services (TIS) provide drug infor-
mation to pregnant women via telephone. To inform planning
of an economic evaluation of TIS, a literature review of previ-
ous program evaluations of maternal health services using dis-
crete choice experiment (DCE) methodology was conducted.
METHODS: A search of the literature in the databases
PubMed, MedLine, and PsychLit, was performed. The search
keywords used were “discrete choice experiment” and “preg-
nancy”. The studies were critically reviewed. RESULTS: Five
previous studies that have applied DCE methods in the context
of pregnancy and maternal health were found. These studies
have examined preferences for service attributes in relation to
miscarriage management, in-vitro fertilization, prenatal screen-
ing for Down’s syndrome, provision of emergency contracep-
tion, and provision of counseling services after rape. These
studies found that preferred service attributes included
good staff attitudes, continuity of care, sympathetic and
non-judgmental treatment, privacy, and sensitive health care pro-
viders. Women were willing to pay to avoid pain and compli-
cations, and for good staff attitudes. CONCLUSION: Women’s
preferences and WTP for health care services that provide drug
information during pregnancy remain unknown. A DCE
approach to evaluating services avoids the methodological chal-
lenges associated with tracking and aggregating health out-
comes in both the mother and her child over their lifetimes.
DCEs are able to demonstrate the value of non-health attributes
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